HomeCompareFLYCX vs JNJ

FLYCX vs JNJ: Dividend Comparison 2026

FLYCX yields 8.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FLYCX wins by $14.6K in total portfolio value
10 years
FLYCX
FLYCX
● Live price
8.29%
Share price
$35.09
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.6K
Annual income
$1,400.14
Full FLYCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FLYCX vs JNJ

📍 FLYCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLYCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLYCX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLYCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLYCX
Annual income on $10K today (after 15% tax)
$704.66/yr
After 10yr DRIP, annual income (after tax)
$1,190.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FLYCX beats the other by $486.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLYCX + JNJ for your $10,000?

FLYCX: 50%JNJ: 50%
100% JNJ50/50100% FLYCX
Portfolio after 10yr
$27.3K
Annual income
$1,113.96/yr
Blended yield
4.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FLYCX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLYCX buys
0
JNJ buys
0
No recent congressional trades found for FLYCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLYCXJNJ
Forward yield8.29%3.36%
Annual dividend / share$2.91$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.6K$20.0K
Annual income after 10y$1,400.14$827.78
Total dividends collected$11.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLYCX vs JNJ ($10,000, DRIP)

YearFLYCX PortfolioFLYCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,529$829.01$10,676$355.77+$853.00FLYCX
2$13,229$893.24$11,407$389.39+$1.8KFLYCX
3$15,113$957.92$12,198$426.53+$2.9KFLYCX
4$17,194$1,022.74$13,056$467.62+$4.1KFLYCX
5$19,485$1,087.43$13,987$513.12+$5.5KFLYCX
6$22,001$1,151.70$14,998$563.56+$7.0KFLYCX
7$24,756$1,215.32$16,098$619.52+$8.7KFLYCX
8$27,767$1,278.07$17,295$681.69+$10.5KFLYCX
9$31,050$1,339.73$18,599$750.82+$12.5KFLYCX
10$34,624$1,400.14$20,022$827.78+$14.6KFLYCX

FLYCX vs JNJ: Complete Analysis 2026

FLYCXStock

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in common stocks of large-capitalization companies, defined as companies that have market capitalizations of $5 billion or greater. It may invest up to 15% of its total assets in non-dollar denominated equity securities of non-U.S. issuers.

Full FLYCX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FLYCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLYCX vs SCHDFLYCX vs JEPIFLYCX vs OFLYCX vs KOFLYCX vs MAINFLYCX vs ABBVFLYCX vs MRKFLYCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.